Frequency, patterns, and preferences of lubricant use during anal intercourse within male sexual partnerships in Lima, Peru: implications for a rectal microbicide HIV prevention intervention.
Understanding current practices of lubricant use during anal intercourse can help to assess the contexts for the introduction of topical rectal microbicides as an HIV prevention tool for men who have sex with men (MSM). We used quantitative and qualitative methods to assess: current patterns of lubricant use; preferred characteristics of commercial lubricant formulations; and social and behavioral contexts of lubricant use within male sexual partnerships in Lima, Peru. Between 2007 and 2008, we conducted a quantitative behavioral survey with 547 MSM followed by qualitative individual and group interviews with 36 MSM from Lima, Peru. Approximately half of all participants in the quantitative survey (50.3%) reported using commercial lubricant during intercourse occasionally or consistently during the preceding two months, with lack of availability at the time of intercourse the most commonly reported reason for non-use. No clear preferences regarding the color, smell, taste, or viscosity of commercial lubricants were identified, and all participants who reported using a commercial lubricant used the same product ("Love-Lub"). In the qualitative analysis, participants characterized lubricant use as a sexual practice consistently controlled by the receptive partner, who typically obtained and applied lubricant independently, with or without the consent of the insertive partner. Quantitative findings supported this differential pattern of lubricant use, with men who reported sexual identities or roles consistent with receptive anal intercourse, including unprotected receptive intercourse, more likely to report lubricant use than MSM who claimed an exclusively insertive sexual role. Given the social, behavioral, and biological factors contributing to increased vulnerability for HIV and STI acquisition by the receptive partner in anal intercourse, delivery of a topical rectal microbicide as a lubricant formulation could provide an important HIV prevention resource for at-risk MSM in Lima, Peru.
David Geffen School of Medicine at UCLA, Department of Medicine, Infectious Diseases/Program in Global Health, Los Angeles, CA, USA. jlclark@mednet.ucla.edu
Jesse L
JL
Clark
Hector J
HJ
Salvatierra
Eddy R
ER
Segura
Ximena
X
Salazar
Kelika
K
Konda
Jerome
J
Galea
Jeffrey D
JD
Klausner
Thomas J
TJ
Coates
Carlos F
CF
Caceres
D000285:Administration, Rectal; D000328:Adult; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D003625:Data Collection; D005069:Evaluation Studies as Topic; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D006679:HIV Seropositivity / Q000453:epidemiology; D018451:Homosexuality, Male / Q000523:psychology* / Q000706:statistics & numerical data; D006801:Humans; D054327:Lubricants / Q000627:therapeutic use*; D008297:Male; D010568:Peru / Q000453:epidemiology; D012725:Sexual Behavior / Q000706:statistics & numerical data; D055815:Young Adult
D000891:Anti-Infective Agents, Local; D054327:Lubricants